Leadership & Pay ·
Pfizer appoints Cecile Guegan as CFO with $1.3M base salary
PFEPfizer Inc
The Board of Directors unanimously elected Cecile Guegan to serve as Chief Financial Officer and Executive Vice President, effective November 1, 2026. She previously served as Interim CFO since August 16, 2026. The Compensation Committee approved an annual base salary of $1,300,000 and a target cash incentive opportunity equal to 100% of her base salary. Guegan brings over 25 years of global finance leadership in the pharmaceutical industry, including prior roles at Wyeth and various senior positions within Pfizer's biopharmaceuticals and R&D divisions. She will oversee all corporate finance functions, including audit, treasury, investor relations, tax, and operations planning. Pfizer Inc. is a premier innovative biopharmaceutical company that discovers, develops, manufactures, and markets health care products, including medicines and vaccines.